Bluejay Diagnostics (BJDX) Capital Expenditures (2021 - 2026)

Bluejay Diagnostics' Capital Expenditures history runs 5 years deep, the most recent figure standing at $18989.0 for Q1 2026.

• In Q1 2026, Capital Expenditures changed N/A year-over-year to $18989.0; the TTM figure through Mar 2026 stood at $290339.0 (changed N/A YoY), while the FY2025 annual figure was $173735.0, down 43.37% from the prior year.
• Capital Expenditures came in at $18989.0 for Q1 2026 at Bluejay Diagnostics, up from $1125.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $791464.0 in Q3 2022 to a low of $227.0 in Q3 2024.
• A 4-year average of $171477.5 and a median of $87894.0 in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 18392.15% in 2022 and tumbled 99.7% in 2024, its largest moves.
• Bluejay Diagnostics' Capital Expenditures stood at $238207.0 in 2022, then tumbled by 63.1% to $87894.0 in 2023, then tumbled by 98.72% to $1125.0 in 2024, then surged by 1587.91% to $18989.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $18989.0, $1125.0, and $227.0 for Q1 2026, Q4 2024, and Q3 2024 respectively.

Peer Comparison